This is a research study being conducted in patients who tested positive for COVID-19 in the past 10 days and are admitted to the hospital. The study is being conducted to assess the safety of an experimental drug called Reparixin. This is provided as tablets along with standard treatment to limit progression of Covid-19 disease. This is a randomized, (which means just like tossing a coin, you will be randomly assigned to receive the study drug or the standard treatment) double-blind trial (which means neither you nor the study team will know which group you are assigned to).
Articles
July 21, 2020
The team at Circle Health Urgent Care is dedicated to serving as a community resource for both patients and our business community. Since early February, our Urgent Care team has been actively managing the pandemic by expediting operational changes and protocols to support the varied needs of patients seeking Urgent Care, as well as municipal workers and first responders such as police and fire departments through Occupational Medicine Services.